Clinical Trial Update: Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II prospective single-arm study evaluating concurrent chemoradiotherapy with toripalimab for locally recurrent nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Nasopharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Cancer Hospital of Guangxi Medical University | Conditions: Nasopharyngeal Carcinoma, Toripalimab | Phase 2 | Status: UNKNOWN